Amir Pelleg
Corporate Officer/Principal bei Drexel University
Profil
Amir Pelleg has been President and Chief Scientific Officer of Duska Therapeutics, Inc. since August 2004.
Previously, he was a Director and Chairman of Duska Therapeutics from 2004 to 2007.
Dr. Pelleg has been President, Chief Scientific Officer and a Director of Duska Scientific since 1996 and Chief Operating Officer since January 2004.
He was a Member of Duska Scientific's Executive Committee.
Dr. Pelleg was a Professor of Medicine and Pharmacology at Drexel University College of Medicine, Philadelphia, Pennsylvania from 1992 to 2004.
He is an Adjunct Professor at Drexel University College of Medicine.
Dr. Pelleg has experience in the physiology and pharmacology of ATP.
He is a Member of the Editorial Board of The American Journal of Therapeutics.
Dr. Pelleg received a BS degree in Biology from Tel-Aviv University, an MS in Bioengineering from the Polytechnic Institute of Brooklyn and a PhD in Human Physiology from Louisiana State University.
Aktive Positionen von Amir Pelleg
| Unternehmen | Position | Beginn |
|---|---|---|
| Drexel University | Corporate Officer/Principal | 01.01.1992 |
Ehemalige bekannte Positionen von Amir Pelleg
| Unternehmen | Position | Ende |
|---|---|---|
Duska Scientific Co.
 Duska Scientific Co. Pharmaceuticals: MajorHealth Technology Part of Cordex Pharma, Inc., Duska Scientific Co. is a company that manufactures biopharmaceutical products. The company is based in Haverford, PA. | Präsident | - |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Präsident | - |
Ausbildung von Amir Pelleg
| Tel-Aviv University | Undergraduate Degree |
| Louisiana State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Duska Scientific Co.
Duska Scientific Co. Pharmaceuticals: MajorHealth Technology Part of Cordex Pharma, Inc., Duska Scientific Co. is a company that manufactures biopharmaceutical products. The company is based in Haverford, PA. | Health Technology |
| Polytechnic University | Consumer Services |
